While this work suggests that the OXTR is a valid target for recovery of cerebrovascular insults, including stroke related to cognitive impairment and dementia (McKay et al., 2019), further mechanistic and validation studies are warranted, especially in reference to ischemic conditions. The gene discussed is OXTR; the disease is stroke disorder.